10-16876998-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001081.4(CUBN):āc.9005A>Gā(p.Glu3002Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,613,950 control chromosomes in the GnomAD database, including 10,219 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001081.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUBN | NM_001081.4 | c.9005A>G | p.Glu3002Gly | missense_variant | 57/67 | ENST00000377833.10 | NP_001072.2 | |
CUBN | XM_011519709.3 | c.4991A>G | p.Glu1664Gly | missense_variant | 31/41 | XP_011518011.1 | ||
CUBN | XM_011519710.3 | c.4967A>G | p.Glu1656Gly | missense_variant | 31/41 | XP_011518012.1 | ||
CUBN | XM_011519711.4 | c.4847A>G | p.Glu1616Gly | missense_variant | 30/40 | XP_011518013.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUBN | ENST00000377833.10 | c.9005A>G | p.Glu3002Gly | missense_variant | 57/67 | 1 | NM_001081.4 | ENSP00000367064.4 |
Frequencies
GnomAD3 genomes AF: 0.129 AC: 19609AN: 152024Hom.: 1442 Cov.: 32
GnomAD3 exomes AF: 0.104 AC: 26075AN: 251364Hom.: 1630 AF XY: 0.105 AC XY: 14198AN XY: 135840
GnomAD4 exome AF: 0.105 AC: 153749AN: 1461808Hom.: 8774 Cov.: 33 AF XY: 0.106 AC XY: 77090AN XY: 727208
GnomAD4 genome AF: 0.129 AC: 19615AN: 152142Hom.: 1445 Cov.: 32 AF XY: 0.125 AC XY: 9299AN XY: 74386
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 07, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Imerslund-Grasbeck syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Imerslund-Grasbeck syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at